Table 1.
Biochemical hypocalcaemia and its association with various parameters
| Parameters | Yes (n = 51) |
p value |
|---|---|---|
| Age (Years) | 47.27 ± 13.69 | 0.2621 |
| Age | 0.8992 | |
| 21–30 Years | 4 (7.8%) | |
| 31–40 Years | 15 (29.4%) | |
| 41–50 Years | 13 (25.5%) | |
| 51–60 Years | 7 (13.7%) | |
| 61–70 Years | 9 (17.6%) | |
| 71–80 Years | 3 (5.9%) | |
| Gender | 0.7132 | |
| Male | 7 (13.7%) | |
| Female | 44 (86.3%) | |
| Neck Swelling (Yes) | 48 (94.1%) | 0.5622 |
| Pressure Symptoms | 0.7112 | |
| No | 48 (94.1%) | |
| Horseness Of Voice | 1 (2.0%) | |
| Dysphagia With Stridor | 1 (2.0%) | |
| Shortness Of Breath | 1 (2.0%) | |
| TFT | 1.0002 | |
| Normal | 50 (98.0%) | |
| Hypothyroidism | 1 (2.0%) | |
| USG Neck | 0.8872 | |
| Tirads 1 | 5 (9.8%) | |
| Tirads 2 | 21 (41.2%) | |
| Tirads 3 | 1 (2.0%) | |
| Tirads 4 | 17 (33.3%) | |
| Tirads 5 | 5 (9.8%) | |
| Thyroiditis | 1 (2.0%) | |
| Solitary Thyroid Nodule | 1 (2.0%) | |
| FNAC: Colloid Goiter (Yes) | 21 (41.2%) | 0.0923 |
| FNAC: Adenomatoid Nodule (Yes) | 4 (7.8%) | 1.0002 |
| FNAC: Papillary Carcinoma (Yes) | 8 (15.7%) | 0.1862 |
| FNAC: Nodular Goiter (Yes) | 2 (3.9%) | 1.0002 |
| FNAC: Follicular Neoplasm (Yes) | 8 (15.7%) | 0.4772 |
| FNAC: Thyroiditis (Yes) | 3 (5.9%) | 0.5682 |
| FNAC: Others (Yes) | 6 (11.8%) | 0.6702 |
| Procedure | 1.0002 | |
| Near Total Thyroidectomy | 5 (9.8%) | |
| Total Thyroidectomy | 46 (90.2%) | |
| Parathyroid (Preserved) | 51 (100.0%) | 1.0003 |
| Inferior Thyroid Artery (Preserved) | 51 (100.0%) | 1.0003 |
| Vitamin D (ng/mL) (Pre-Operative) | 19.18 ± 9.09 | 0.2164 |
| Vitamin D (Pre-Operative) | 0.3852 | |
| <20 ng/mL | 33 (64.7%) | |
| 20–30 ng/mL | 14 (27.5%) | |
| ≥30 ng/mL | 4 (7.8%) | |
| PTH (pg/mL) (Pre-Operative) | 48.05 ± 20.03 | 0.8484 |
| PTH (pg/mL) (Post-Operative 4 h)*** | 19.00 ± 16.02 | 0.0014 |
| PTH (Pre-Operative) | 0.7152 | |
| 15–65 pg/mL | 42 (82.4%) | |
| >65 pg/mL | 9 (17.6%) | |
| PTH (Post-Operative 4 h)*** | < 0.0013 | |
| <15 pg/mL | 28 (54.9%) | |
| 15–65 pg/mL | 23 (45.1%) | |
| Calcium (mg/dL) (Pre-Operative) | 9.04 ± 0.44 | 0.2304 |
| Calcium (mg/dL) (POD 1)*** | 8.16 ± 0.57 | < 0.0011 |
| Calcium (mg/dL) (POD 2–4)*** | 7.78 ± 0.60 | < 0.0014 |
| Calcium (mg/dL) (3 Months) | 8.99 ± 0.87 | 0.0614 |
| Biochemical Hypocalcemia (Pre-Operative) (Yes) | 8 (15.7%) | 0.1012 |
| Biochemical Hypocalcemia (POD 1) (Yes)*** | 42 (60.0%) | < 0.0013 |
| Biochemical Hypocalcemia (POD 2–4) (Yes)*** | 51 (73.9%) | < 0.0013 |
| Biochemical Hypocalcemia (3 Months) (Yes) | 10 (22.7%) | 0.0982 |
| Symptomatic Hypocalcemia (Yes)*** | 25 (49.0%) | 0.0013 |
| Post Operative Complications | 1.0002 | |
| No | 49 (96.1%) | |
| Horseness Of Voice | 2 (3.9%) | |
| Post Operative Management: No (Yes) | 9 (17.6%) | 0.1022 |
| Post Operative Management: IV Calcium (Yes)*** | 18 (35.3%) | 0.0152 |
| Post Operative Management: Oral Calcium (Yes) | 41 (80.4%) | 0.1212 |
| Post Operative Management: Vitamin D (Yes) | 14 (27.5%) | 0.5282 |
| Discharged with Calcium Supplementation: No (Yes) | 9 (18.4%) | 0.2052 |
| Discharged with oral Calcium and vitamin DSupplementation | 40 (81.6%) | 0.2052 |
| Final HPE Impression | 1.0003 | |
| Benign | 34 (66.7%) | |
| Malignant | 17 (33.3%) | |
| Change in PTH (pg/mL) (Post-Operative 4 h)*** | -29.05 ± 22.81 | 0.0324 |